Cycle for the Cure offers more locations and activities supporting TGen cancer research

Organizers add Chandler and Phoenix health clubs in May 1 quest to raise a record $200,000

PHOENIX, Ariz. - March 3, 2016 - The 6th annual Cycle for the Cure on May 1 - one of the most exciting ways to support cancer research at theTranslational Genomics Research Institute (TGen) - is bigger than ever for 2016.

Slots are quickly selling out for the 2-hour, heart-pumping indoor cycling events, hosted by the all four Village Health Clubs and Studio 360. Cycle for the Cure organizers hope to raise a record $200,000 this year, eclipsing the $182,000 raised for TGen cancer research in 2015.

Riding slots require a minimum $200 tax-deductible donation, and riders are encouraged to raise additional research funds.

Two locations have been added this year:
• The recently opened Ocotillo Village Health Club & Spa, 4200 S. Alma School Road, Chandler; 8-10 a.m.
• Studio 360, 3627 E. Indian School Road, #102, Phoenix; 12-2 p.m.

Returning sites are:
• Gainey Village Health Club & Spa, 7477 E. Doubletree Ranch Road, Scottsdale; 8-10 a.m.
• DC Ranch Village Health Club & Spa, 18501 N. Thompson Peak Parkway, Scottsdale; 10 a.m.-12 p.m.
• Camelback Village Racquet & Health Club, 4444 E. Camelback Road, Phoenix; 3-5 p.m.

In addition, Cycle for the Cure this year includes yoga classes for $50 donations:
• DC Ranch, 90-minute hot yoga; 10 a.m.
• Camelback Village, 90-minute yoga; 3:30 p.m.

All locations welcome non-members to participate in Cycle for the Cure. Registration starts today, March 3, at Corporate sponsorships are available: Platinum, $7,500 and higher; Gold, $5,000; Silver, $2,500; and Bronze, $1,000.

A post-ride party for all participants from all the clubs will be hosted at Camelback Village at 5 p.m., following the last ride. It will feature a return musical performance by Nate Nathan and MacDaddy-o's band, which was a huge hit last year. The party is free for riders; $20 donation for guests.

Using genomic sequencing, TGen helps doctors match the appropriate therapy to each patient's DNA profile, producing the greatest patient benefit. This year, Cycle for the Cure is focused on raising research funds for work on a revolutionary diagnostic method called "liquid biopsies" - biomarkers in circulating blood - as a means of providing patients and their doctors with early detection of disease.

Dr. Jeffrey Trent, TGen President and Research Director, will be among TGen's renowned scientists participating in Cycle for the Cure.

"Funds raised by Cycle for the Cure remain in Arizona for TGen research. Local research means local patients benefit first," said Robyn DeBell, one of the event's co-chairs. "Being involved in TGen is like having a sneak peak at the future of medicine."

"Cycle for the Cure is getting bigger and more exciting every year," said Vicki Vaughn, the event's other co-chair. "In supporting this event, the public not only supports TGen, but also supports the economic impact - now at $174 million annually - that TGen provides Arizona."

"TGen is so very fortunate to have collaborative partners like the Village Health Clubs and to the dynamic volunteers like Robyn DeBell and Vicki Vaughn who work tirelessly to advance TGen's research," said TGen Foundation President Michael Bassoff. "Cycle for the Curehelps us provide hope and answers for cancer patients and their families who need our help today."

# # #

About TGen
Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. TGen is focused on helping patients with neurological disorders, cancer, and diabetes, through cutting edge translational research (the process of rapidly moving research towards patient benefit). TGen physicians and scientists work to unravel the genetic components of both common and rare complex diseases in adults and children. Working with collaborators in the scientific and medical communities literally worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. For more information, Follow TGen onFacebook,LinkedInandTwitter @TGen.

Press Contacts:
Steve Yozwiak
TGen Senior Science Writer
[email protected]

Media Contact

RSS Feed